Ony Biotech
Ony Biotech, a leading name in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2015, the company has rapidly established itself as a pioneer in the development of innovative diagnostic solutions and therapeutic products, particularly in the fields of infectious diseases and immunology. Ony Biotech's core offerings include advanced molecular diagnostics and cutting-edge biopharmaceuticals, distinguished by their precision and efficacy. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. With a commitment to scientific excellence and patient-centric solutions, Ony Biotech continues to drive advancements in healthcare, making a notable impact in the biotechnology landscape.
DitchCarbon Score
How does Ony Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ony Biotech's score of 3 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ony Biotech's reported carbon emissions
Ony Biotech, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or initiatives documented. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the absence of data may indicate a need for enhanced transparency in their environmental practices. As the industry increasingly prioritises climate action, it is essential for companies like Ony Biotech to establish clear emissions reduction goals and report on their progress to align with global sustainability standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ony Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
